Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: A multivariate analysis of prognostic factors
Luca Mondazzi, Riccardo Bottelli, Giorgio Brambilla, Antonio Rampoldi, Indira Rezakovic, Claudio Zavaglia, Alberto Alberti, Gaetano Idèo – 1 May 1994 – A total of 84 patients with hepatocellular carcinoma and cirrhosis were analyzed retrospectively to investigate prognostic factors. All patients received transarterial oily chemoembolization as the only anticancer therapy. The follow‐up range was 1 to 39 mo (median, 9.5 mo). The overall actuarial survival rates at 12, 24 and 30 mo were 62%, 31% and 24%, respectively.